The Center for Reproductive Medicine, Obstetrics and Gynecology Department, The Second Affiliated Hospital of Chongqing Medical University, No. 288 Tianwen Avenue, Nanan District, Chongqing, 400010, People's Republic of China.
Prenatal Diagnosis Center, Obstetrics and Gynecology Department, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, China.
J Assist Reprod Genet. 2023 Oct;40(10):2473-2483. doi: 10.1007/s10815-023-02904-x. Epub 2023 Aug 12.
The purpose of this study was to investigate alterations in serum metabolites during endometrial transformation and possible associations with recurrent implantation failure (RIF) in hormonal replacement therapy (HRT)-frozen embryo transfer (FET) cycles.
We performed a prospective study involving 100 patients scheduled for HRT-FET cycles during January 2022 to April 2022. Blood serum samples were collected on the day of progesterone administration (dPA) and on the third day of progesterone administration (d3PA). Gas chromatography-mass spectrometry (GC-MS) analysis was performed to identify and quantify serum metabolites. A nested case-control study including 19 RIF patients and 19 matching controls was conducted to explore the predictive value of serum metabolites for RIF. Partial least squares discriminant analysis (PLS-DA) and receiver operating characteristic (ROC) curve analysis were performed to establish prediction models.
We identified 105 serum metabolites, with 76 of them exhibiting significant alterations during the initial 3 days of endometrial transformation. Metabolites involved in amino acid metabolism and tricarboxylic acid (TCA) cycle showed lower levels during endometrial transformation. In the nested case-control study, the prediction model based on the ratio of serum metabolites between d3PA and dPA showed the highest area under the ROC curve (AUC), accuracy, and R and Q values. Eight metabolites, including indol-3-propionic acid, beta-alanine, myristoleic acid, malic acid, indole, DL-isocitric acid, proline, and itaconic acid, exhibited high predictive values for RIF.
This study demonstrates alterations in serum metabolites during endometrial transformation, particularly in amino acid metabolism and TCA cycle. The identified metabolites, especially indol-3-propionic acid and malic acid, show potential as predictive markers for RIF. These findings contribute to a better understanding of the metabolic changes associated with endometrial receptivity and provide insights for the development of personalized approaches to improve implantation outcomes in FET cycles.
本研究旨在探讨激素替代治疗(HRT)-冻融胚胎移植(FET)周期中子宫内膜转化过程中血清代谢物的变化及其与反复种植失败(RIF)的可能关联。
我们进行了一项前瞻性研究,纳入了 2022 年 1 月至 4 月期间计划接受 HRT-FET 周期的 100 名患者。在孕激素给药日(dPA)和孕激素给药第 3 天(d3PA)采集血清样本。采用气相色谱-质谱联用(GC-MS)分析鉴定和定量血清代谢物。进行了一项巢式病例对照研究,纳入了 19 例 RIF 患者和 19 例匹配对照,以探讨血清代谢物对 RIF 的预测价值。采用偏最小二乘判别分析(PLS-DA)和受试者工作特征(ROC)曲线分析建立预测模型。
我们共鉴定出 105 种血清代谢物,其中 76 种在子宫内膜转化的最初 3 天内发生显著变化。代谢物涉及氨基酸代谢和三羧酸(TCA)循环,在子宫内膜转化过程中水平降低。在巢式病例对照研究中,基于 d3PA 和 dPA 之间血清代谢物比值的预测模型显示出最高的 ROC 曲线下面积(AUC)、准确性和 R 和 Q 值。8 种代谢物,包括吲哚-3-丙酸、β-丙氨酸、豆蔻酸、苹果酸、吲哚、DL-异柠檬酸、脯氨酸和衣康酸,对 RIF 具有较高的预测价值。
本研究表明子宫内膜转化过程中血清代谢物发生变化,特别是在氨基酸代谢和 TCA 循环中。鉴定出的代谢物,特别是吲哚-3-丙酸和苹果酸,可能作为 RIF 的预测标志物。这些发现有助于更好地了解与子宫内膜容受性相关的代谢变化,并为开发改善 FET 周期中种植结局的个体化方法提供了新的思路。